Jane Street Group, LLC Chemomab Therapeutics Ltd. Transaction History
Jane Street Group, LLC
- $481 Billion
- Q2 2025
A detailed history of Jane Street Group, LLC transactions in Chemomab Therapeutics Ltd. stock. As of the latest transaction made, Jane Street Group, LLC holds 20,569 shares of CMMB stock, worth $63,146. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,569Holding current value
$63,146% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CMMB
# of Institutions
14Shares Held
4.22MCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY1.61MShares$4.96 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA941KShares$2.89 Million0.04% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3738KShares$2.27 Million0.24% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3578KShares$1.78 Million0.12% of portfolio
-
Ikarian Capital, LLC Dallas, TX213KShares$654,0690.08% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $35.1M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...